Table 1.
Summary of mouse tumors studied by Affymetrix microarray profiling
| Tumors | Cited as | Exogenous gene effect | Tumor type | Site of origin | N |
| PCT-1 | ABLMYCPC | v-Abl + c-Myc | Virus-accelerated ip PCT | intraperitoneal | 7 |
| PCT-2 | ABPC | v-Abl | Virus-accelerated ip PCT | intraperitoneal | 12 |
| PCT-3 | J3PC | v-Raf + v-Myc | Virus-accelerated ip PCT | intraperitoneal | 4 |
| PCT-4 | KiPC | IL-6 transgene | Transgene-accelerated ip PCT | intraperitoneal | 3 |
| PCT-5 | IL6PC | IL-6 transgene | Spontaneous PCT | gut-associated lymphoid tissue | 8 |
| PCT-6 | TEPC, LPC, MOPC | none | Pristane oil-induced ip PCT | intraperitoneal | 18 |
| BCL-1 | IL6LN | IL-6 transgene | Spontaneous pre-malignant PCT | gut-associated lymphoid tissue | 6 |
| BCL-2 | Pre B v-Abl (a.k.a. ABLS) | v-Abl | Virus-accelerated Pre-B lymphoma | bone marrow + spleen | 6 |
| BCL-3 | BCLEμ | c-Myc in Igμ locus | Spontaneous BCL | lymph nodes | 3 |
| BCL-4 | BCLCα | c-Myc in Igα locus | Spontaneous BCL | lymph nodes | 3 |